Navigation Links
Unilens Vision Reports Record First Quarter Revenue, Earnings and Royalty Income
Date:11/21/2008

the adequacy or accuracy of this release.

    For more information, please contact:
    Leonard F. Barker, CFO, Unilens Vision Inc. at (727) 544-2531



                              UNILENS VISION INC.
                         FIRST QUARTER - FISCAL 2009
                CONDENSED CONSOLIDATED FINANCIAL INFORMATION

    (All figures in U.S. Dollars)
    RESULTS OF OPERATIONS
                                                  Three Months   Three Months
                                                     Ended          Ended
                                                 Sept. 30, 2008 Sept. 30, 2007

       Sales                                       $1,761,526     $1,673,361
       Cost of sales                                  935,132        904,397
                                                      826,394        768,964
       Expenses                                       771,961        754,952
       Income from operations                          54,433         14,012
       Other items:
       Royalty income                                 713,397        612,799
       Other income (expense)                           2,585        (27,141)
       Remeasurement (loss) income                     (4,427)         2,541
       Interest income                                  2,271         14,290
                                                      713,826        602,489
       Income before income tax                       768,259        616,501
       Income tax expense                             301,892        239,205
       Net income for the period                     $466,367       $377,296
       Net income per common share:
         Basic                                          $0.10          $0.08
         Diluted                                        $0.10          $0.08
    CASH FLOWS
    Provided (used) by:
       Operating activities                          $706,683       $689,258
       Inves
'/>"/>
SOURCE  Unilens Vision Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 

Related medicine news :

1. Unilens Launches New C-VUE(R) Advanced(TM) Custom Toric Lens
2. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
3. Unilens Vision Announces New Policies Aimed at Increasing Eye Care Professionals Profitability
4. Unilens Vision Reports Increased Royalty Income
5. Unilens Launches Aspheric C-VUE(R) Daily Disposable Lens
6. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
7. Unilens Vision Reports 70% Increase in Second Quarter Earnings on Higher Sales and Record Royalty Income
8. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
9. Unilens Vision Reports Record First Quarter Earnings and Royalty Income
10. Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens
11. OmniVision Unveils 1.8 mm, Low Power Medical Sensor With Best-in-Class Low Light Performance
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Vivakor Announces New Acquisition Strategy 2Millstone Medical Outsourcing Appoints New Leadership of Memphis Facility 2Gambling Addiction Expert Says Treatment Tops Prohibition 57554 1Gambling Addiction Expert Says Treatment Tops Prohibition 57554 2Consumer Watchdog Says Insurers Must Answer Questions About Use of Employees as Mini Lobbyists in Congress 57549 1Consumer Watchdog Says Insurers Must Answer Questions About Use of Employees as Mini Lobbyists in Congress 57549 2WellPoint Named to 2009 InformationWeek 500 List of Top Technology Innovators 57544 1WellPoint Named to 2009 InformationWeek 500 List of Top Technology Innovators 57544 2WellPoint Named to 2009 InformationWeek 500 List of Top Technology Innovators 57544 3